Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease
- PMID: 16837857
- DOI: 10.1097/01.wnr.0000227984.84927.a7
Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease
Abstract
We carried out an investigation to identify neuromelanin-containing noradrenergic and dopaminergic neurons in the locus ceruleus and substantia nigra pars compacta of healthy volunteers and patients with Parkinson's disease using a newly developed magnetic resonance imaging technique that can demonstrate neuromelanin-related contrast. The high-resolution neuromelanin images obtained by a 3-T scanner revealed high signal areas in the brain stem and these corresponded well with the location of the locus ceruleus and substantia nigra pars compacta in gross specimens. In Parkinson's disease patients, the signal intensity in the locus ceruleus and substantia nigra pars compacta was greatly reduced, suggesting depletion of neuromelanin-containing neurons. We conclude that neuromelanin magnetic resonance imaging can be used for direct visualization of the locus ceruleus and substantia nigra pars compacta, and may help in detecting pathological changes in Parkinson's disease and related disorders.
Similar articles
-
T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.Mov Disord. 2011 Aug 1;26(9):1633-8. doi: 10.1002/mds.23722. Epub 2011 Apr 12. Mov Disord. 2011. PMID: 21491489
-
Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging.Neurosci Lett. 2013 Apr 29;541:93-8. doi: 10.1016/j.neulet.2013.02.012. Epub 2013 Feb 18. Neurosci Lett. 2013. PMID: 23428505
-
Monoamine neurons in the human brain stem: anatomy, magnetic resonance imaging findings, and clinical implications.Neuroreport. 2008 Nov 19;19(17):1649-54. doi: 10.1097/WNR.0b013e328315a637. Neuroreport. 2008. PMID: 18852680 Review.
-
Use of neuromelanin-sensitive MRI to distinguish schizophrenic and depressive patients and healthy individuals based on signal alterations in the substantia nigra and locus ceruleus.Biol Psychiatry. 2008 Sep 1;64(5):401-6. doi: 10.1016/j.biopsych.2008.03.021. Epub 2008 May 1. Biol Psychiatry. 2008. PMID: 18452894
-
The enigma of neuromelanin in Parkinson's disease substantia nigra.J Neural Transm Suppl. 1994;43:113-22. J Neural Transm Suppl. 1994. PMID: 7884393 Review.
Cited by
-
Substantia nigra volume loss before basal forebrain degeneration in early Parkinson disease.JAMA Neurol. 2013 Feb;70(2):241-7. doi: 10.1001/jamaneurol.2013.597. JAMA Neurol. 2013. PMID: 23183921 Free PMC article.
-
The Role of Magnetic Resonance Imaging for the Diagnosis of Atypical Parkinsonism.Front Neurol. 2020 Jul 17;11:665. doi: 10.3389/fneur.2020.00665. eCollection 2020. Front Neurol. 2020. PMID: 32765399 Free PMC article. Review.
-
Evaluation of the Swallow-Tail Sign and Correlations of Neuromelanin Signal with Susceptibility and Relaxations.Tomography. 2021 Mar 27;7(2):107-119. doi: 10.3390/tomography7020010. Tomography. 2021. PMID: 33801685 Free PMC article.
-
Unraveling the contributions to the neuromelanin-MRI contrast.Brain Struct Funct. 2020 Dec;225(9):2757-2774. doi: 10.1007/s00429-020-02153-z. Epub 2020 Oct 22. Brain Struct Funct. 2020. PMID: 33090274 Free PMC article.
-
MRI biomarkers of motor and non-motor symptoms in Parkinson's disease.Parkinsonism Relat Disord. 2020 Apr;73:85-93. doi: 10.1016/j.parkreldis.2019.10.002. Epub 2019 Oct 10. Parkinsonism Relat Disord. 2020. PMID: 31629653 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous